{"text_format":"1","workbook":"xlsx","n_sheets":24,"sheets":["Summary","Front Page","1. Market Data","2. UE by LOB and Net Income","3. UE by Geography","4. Shares & UEPS","5. P&C UE by Sub LOB","6. P&C UE by Geography","7. L&H UE by LOB","8. L&H UE by Geography","9. Life UE by Geography","10. Health UE by Geography","11. Asset Management","12. Holdings","13. Activity indicators","14. Balance Sheet","15.CSM Rollforward","16. FY22 Invested Assets","17. Supplementary Info on Asset","18. Shareholders Equity","19. ROE&Gearing","20. Information on Solvency II","21. IFRS17 SHE to Group EOF","Holding & Banking"],"not_rendered":{"charts":0,"images":1,"macros":1,"external_links":8,"defined_names":1074,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900"}

{"sheet":"Summary","index":0,"n_rows":27,"n_cols":20,"rows_kept":27,"cut":false,"hidden":false,"merged":[]}
[]
["Financial Supplement - Table of Contents"]
["","","","","","","","","","","","","","","","","","","",""]
["","","","","","","","","","","","","","","","","","","",""]
[]
["Front Page"]
["1. Market Data"]
["2. UE by LOB and Net Income"]
["3. UE by Geography"]
["4. Shares & UEPS"]
["5. P&C UE by Sub LOB"]
["6. P&C UE by Geography"]
["7. L&H UE by LOB"]
["8. L&H UE by Geography"]
["9. Life UE by Geography"]
["10. Health UE by Geography"]
["11. Asset Management"]
["12. Holdings"]
["13. Activity indicators"]
["14. Balance Sheet"]
["15.CSM Rollforward"]
["16. Economic View of Invested Assets"]
["17. Supplementary Information on Economic View of Invested Assets as at December 31, 2022"]
["18. Shareholders Equity"]
["19. ROE&Gearing"]
["20. Information on Solvency II"]
["21. IFRS17 SHE to Group EOF"]

{"sheet":"Front Page","index":1,"n_rows":30,"n_cols":8,"rows_kept":30,"cut":false,"hidden":false,"merged":[[3,3,3,22],[11,3,11,22]]}
["Back to Summary"]
[]
[]
[null,null,null,"Half Year and Full Year 2022 Earnings / May 15, 2023"]
[]
[]
[]
[]
[]
[]
[]
[null,null,null,"Financial Supplement under IFRS17/9"]
[null,null,null,null,null,null,null,""]
[null,null,null,null,null,null,null,""]
[null,null,null,null,null,null,null,""]
[null,null,null,null,null,null,null,""]
[null,null,null,null,null,null,null,""]
[null,null,null,null,null,null,null,""]
[null,null,null,null,null,null,null,""]
[null,null,null,null,null,null,null,""]
[null,null,null,null,null,null,null,""]
[null,null,null,null,null,null,null,""]
[]
[]
[""]
[]
[]
[]
[]
[""]

{"sheet":"1. Market Data","index":2,"n_rows":27,"n_cols":6,"rows_kept":27,"cut":false,"hidden":false,"merged":[]}
["Back to Summary"]
[]
[]
["Exchange Rate",null,"2022-06-30","2022-12-31","Average \nJune 30, 2022","Average \nDecember 31, 2022"]
["USD",null,1.05,1.07,1.0900000000000001,1.05]
["JPY",null,142,141,134,138]
["GBP",null,0.86,0.89,0.84,0.85]
["CHF",null,1,0.99,1.03,1]
["HKD",null,8.1999999999999993,8.33,8.56,8.25]
[]
[]
[]
["Discount Rate - 5Y",null,"Average\nDecember 31,2021","Average\nJune 30, 2022","Average\nDecember 31, 2022"]
["EUR",null,-2.2000000000000001E-3,5.7000000000000002E-3,1.5599999999999999E-2]
["USD",null,1.1900000000000001E-2,2.3199999999999998E-2,3.2899999999999999E-2]
["JPY",null,-8.9999999999999998E-4,-5.9999999999999995E-4,-2.0000000000000001E-4]
["GBP",null,7.7999999999999996E-3,1.7399999999999999E-2,2.9499999999999998E-2]
["CHF",null,-3.8E-3,2.3999999999999998E-3,8.5000000000000006E-3]
["HKD",null,9.2999999999999992E-3,1.9300000000000001E-2,2.87E-2]
[]
["Discount Rate - 10Y",null,"Closing\nDecember 31,2021","Closing\n June 30, 2022","Closing\nDecember 31, 2022"]
["EUR",null,3.7000000000000002E-3,2.47E-2,3.4200000000000001E-2]
["USD",null,1.9099999999999999E-2,3.78E-2,4.4299999999999999E-2]
["JPY",null,6.9999999999999999E-4,3.0000000000000001E-3,5.3E-3]
["GBP",null,1.18E-2,2.86E-2,4.19E-2]
["CHF",null,2E-3,1.84E-2,2.0899999999999998E-2]
["HKD",null,1.5900000000000001E-2,3.56E-2,3.9699999999999999E-2]

{"sheet":"2. UE by LOB and Net Income","index":3,"n_rows":40,"n_cols":16,"rows_kept":40,"cut":false,"hidden":false,"merged":[[39,0,39,15],[1,0,1,15],[2,14,2,15],[3,14,3,15],[5,0,6,0],[5,2,5,3],[5,5,5,6],[5,8,5,9],[5,11,5,12],[5,14,5,15]]}
["Back to Summary"]
["GROUP UNDERLYING EARNINGS BY LINE OF BUSINESS AND NET INCOME"]
[null,null,null,null,null,null,null,null,null,null,null,null,null,null,"AXA Consolidated"]
["(in Euro million)",null,null,null,null,null,null,null,null,null,null,null,null,null,"Financial Statements"]
[null,null,null,null,null,"Property & Casualty",null,null,null,null,null,"Asset Management"]
["Group Underlying Earnings by Line of Business and Net Income",null,"Group",null,null,"Property & Casualty",null,null,"Life & Health",null,null,"Asset Management",null,null,"Holdings* "]
[null,null,"2022-06-30","2022-12-31",null,"2022-06-30","2022-12-31",null,"2022-06-30","2022-12-31",null,"2022-06-30","2022-12-31",null,"2022-06-30","2022-12-31"]
["Short-term Business"]
["Revenues",null,32261,66647,null,24614,50798,null,7647,15849]
["Combined Ratio",null,null,null,null,0.96199999999999997,0.97599999999999998,null,0.96899999999999997,0.97499999999999998]
["Technical Margin",null,1184,1609,null,944,1213,null,241,396]
["Long-term Business"]
["CSM Release",null,1454,3013,null,null,null,null,1454,3013]
["Technical Experience",null,-66,-216,null,null,null,null,-66,-216]
["Financial Result & Other"]
["Financial Result",null,1992,3839,null,1288,2504,null,626,1103,null,2,1,null,77,230]
["Other Revenues",null,1447,2691,null,null,null,null,null,null,null,947,1916,null,500,774]
["Other Expenses",null,-1424,-2756,null,null,null,null,null,null,null,-682,-1404,null,-741,-1352]
["Debt Financing Charges",null,-363,-759,null,null,null,null,null,null,null,null,null,null,-363,-759]
["Underlying Earnings Before Tax",null,4225,7421,null,2231,3718,null,2255,4296,null,267,513,null,-528,-1107]
["Tax",null,-818,-1468,null,-455,-781,null,-437,-849,null,-71,-130,null,146,292]
["Income from Affiliates & Other",null,143,288,null,20,74,null,109,185,null,13,30,null,"-","-"]
["Minority Interests",null,-82,-162,null,-47,-80,null,-30,-69,null,-5,-14,null,"-","-"]
["Underlying Earnings Group Share",null,3467,6080,null,1750,2931,null,1897,3563,null,203,400,null,-383,-814]
["Underlying Earnings Growth Rate (constant FX) (will be available by HY23/FY23)"]
[]
["Underlying ROE (will be available by Line of Business by FY23)",null,0.13700000000000001,0.121]
[]
["Net Realized Capital Gains & Losses",null,-80,-293]
["Change in Fair Value of Assets & Derivatives",null,797,-124]
["Amortization of customer intangibles",null,-201,-280]
["Restructuring Costs",null,-143,-287]
["Exceptional Items",null,7,-41]
["Net Income Group Share",null,3847,5055]
[]
["Deeply Subordinated and Undated Subordinated Debt Charges",null,-91,-182]
["Underlying Earnings for EPS calculation",null,3376,5898]
["Net Income for EPS calculation",null,3756,4873]
[]
["*Includes Bank with Underlying Earnings Group Share of Euro -5 million in June 30,2022 and Euro -27 million in December 31,2022."]

{"sheet":"3. UE by Geography","index":4,"n_rows":32,"n_cols":22,"rows_kept":32,"cut":false,"hidden":false,"merged":[[5,20,5,21],[31,0,31,6],[1,0,1,21],[2,20,2,21],[3,20,3,21],[5,0,6,0],[5,2,5,3],[5,5,5,6],[5,8,5,9],[5,11,5,12],[5,14,5,15],[5,17,5,18]]}
["Back to Summary"]
["UNDERLYING EARNINGS BY GEOGRAPHY"]
[null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"AXA Consolidated"]
["(in Euro million)",null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Financial Statements"]
[null,null,null,null,null,"France",null,null,"Europe",null,null,"AXA XL",null,null,"Asia, Africa & EME-LATAM",null,null,null,null,null,"Transversal & Other"]
["Underlying Earnings by Geography",null,"Group",null,null,"France",null,null,"Europe",null,null,"AXA XL",null,null,"Asia, Africa & EME-LATAM",null,null,"AXA IM",null,null,"Transversal & Other"]
[null,null,"2022-06-30","2022-12-31",null,"2022-06-30","2022-12-31",null,"2022-06-30","2022-12-31",null,"2022-06-30","2022-12-31",null,"2022-06-30","2022-12-31",null,"2022-06-30","2022-12-31",null,"2022-06-30","2022-12-31"]
["Short-term Business"]
["Revenues",null,32261,66647,null,8980,18462,null,10053,20512,null,8930,18777,null,3359,6950,null,null,null,null,940,1946]
["Combined Ratio"]
["Technical Margin",null,1184,1609,null,234,-119,null,330,739,null,648,1119,null,29,-46,null,null,null,null,-57,-84]
["Long-term Business"]
["CSM Release",null,1454,3013,null,423,944,null,475,940,null,3,3,null,554,1126,null,null,null,null,0,0]
["Technical Experience",null,-66,-216,null,-50,-74,null,21,-7,null,-2,-3,null,-34,-132,null,null,null,null,0,0]
["Financial Result & Other"]
["Financial Result",null,1992,3839,null,458,879,null,866,1621,null,265,563,null,311,526,null,2,1,null,90,249]
["Other Revenues",null,1447,2691,null,80,137,null,0,-1,null,"-","-",null,0,-6,null,947,1916,null,420,644]
["Other Expenses",null,-1424,-2756,null,-85,-170,null,6,49,null,"-","-",null,-9,-15,null,-682,-1404,null,-653,-1215]
["Debt Financing Charges",null,-363,-759,null,"-","-",null,0,-3,null,-42,-67,null,-6,-13,null,null,null,null,-315,-676]
["Underlying Earnings Before Tax",null,4225,7421,null,1059,1597,null,1697,3339,null,871,1615,null,845,1439,null,267,513,null,-515,-1083]
["Tax",null,-818,-1468,null,-206,-337,null,-352,-710,null,-174,-314,null,-175,-305,null,-71,-130,null,161,327]
["Income from Affiliates & Other",null,143,288,null,3,13,null,0,0,null,"-","-",null,126,246,null,13,30,null,0,"-"]
["Minority Interests",null,-82,-162,null,-2,-3,null,-47,-114,null,-1,0,null,-27,-32,null,-5,-14,null,0,0]
["Underlying Earnings Group share",null,3467,6080,null,855,1270,null,1298,2514,null,696,1302,null,770,1349,null,203,400,null,-355,-755]
[]
[]
["Underlying Earnings Group Share by Line of Business"]
["Property & Casualty",null,1750,2931,null,234,117,null,627,1191,null,729,1352,null,180,296,null,null,null,null,-21,-26]
["Life & Health",null,1897,3563,null,626,1180,null,647,1266,null,9,17,null,613,1095,null,null,null,null,2,4]
["Asset Management",null,203,400,null,null,null,null,null,null,null,null,null,null,null,null,null,203,400]
["Holdings*",null,-383,-814,null,-5,-27,null,24,57,null,-42,-67,null,-23,-43,null,null,null,null,-336,-734]
["*Includes Bank with Underlying Earnings Group Share of Euro -5 million in June 30,2022 and Euro -27 million in December 31,2022."]

{"sheet":"4. Shares & UEPS","index":5,"n_rows":35,"n_cols":7,"rows_kept":35,"cut":false,"hidden":false,"merged":[[1,0,1,6],[5,0,6,0],[34,0,34,6]]}
["Back to Summary"]
["NUMBER OF SHARES & EARNINGS PER SHARE"]
[null,null,null,null,null,null,"AXA Consolidated "]
["(in million shares) ",null,null,null,null,null,"Financial Statements "]
[]
[null,null,"2022-06-30","2022-12-31",null,"2022-06-30","2022-12-31"]
[null,null,"Outstanding Shares Excluding Treasury Shares (a)","Outstanding Shares Excluding Treasury Shares (a)",null,"Weighted Average Number","Weighted Average Number"]
["Basic Number of Shares"]
["As of Beginning of Period",null,2355.5,2355.5,null,2355.5,2355.5]
["Increase of Capital Dedicated to Employees",null,"-",14,null,"-",1.4]
["Exercice of Stock-options",null,0.6,2.1,null,0.5,0.8]
["Other Movement of Treasury Shares",null,33.700000000000003,-21.2,null,32.1,14.2]
["Capital Increase / (Decrease)",null,-85.9,-85.9,null,-77.400000000000006,-81.7]
["As at End of Period",null,2303.9,2264.5]
["During the Period",null,null,null,null,2310.6999999999998,2290.3000000000002]
[]
["Fully Diluted Number of Shares"]
["Stock Options",null,null,null,null,1.2,0.8]
["Performance Shares",null,null,null,null,5.0999999999999996,6.6]
["During the Period (A)",null,null,null,null,2317.1,2297.6999999999998]
[]
["Earnings Group Share:"]
["Net Income",null,null,null,null,3847,5055]
["Underlying Earnings",null,null,null,null,3467,6080]
["Impact of undated and deeply subordinated debts:"]
["Undated and deeply subordinated debt charges",null,null,null,null,-91,-182]
["Underlying Earnings",null,null,null,null,-91,-182]
["Earnings  for EPS Calculation:"]
["Net Income for EPS Calculation (B)",null,null,null,null,3756,4873]
["Underlying Earnings for EPS Calculation (C)",null,null,null,null,3376,5898]
[]
["Fully Diluted Euro per Share (EPS)"]
["EPS (B/A)",null,null,null,null,1.62,2.12]
["Underlying EPS (C/A)",null,null,null,null,1.46,2.57]
["*Includes Bank with Underlying Earnings Group Share of Euro -5 million in June 30, 2022 and Euro -27 million in December 31, 2022.."]

{"sheet":"5. P&C UE by Sub LOB","index":6,"n_rows":41,"n_cols":11,"rows_kept":41,"cut":false,"hidden":false,"merged":[[1,0,1,10],[2,9,2,10],[3,9,3,10],[5,0,6,0],[5,2,5,5],[5,7,5,10]]}
["Back to Summary"]
["PROPERTY & CASUALTY PROFITABILITY ANALYSIS BY LINE OF BUSINESS"]
[null,null,null,null,null,null,null,null,null,"AXA Consolidated"]
["(in Euro million)",null,null,null,null,null,null,null,null,"Financial Statements"]
[null,null,"Total Group","Commercial","Personal","XLRE",null,"Total Group","Commercial","Personal","XLRE"]
["Property & Casualty Underlying Earnings by Line of Business",null,"2022-06-30",null,null,null,null,"2022-12-31"]
[null,null,"Total","Commercial \nlines","Personal\n lines","AXA XL \nReinsurance",null,"Total","Commercial \n lines","Personal\nlines","AXA XL \nReinsurance"]
["Short-term Business"]
["Revenues",null,24614,16188,8255,1447,null,50798,33606,16687,2968]
["Current Accident Year Loss Ratio",null,0.70799999999999996,0.71599999999999997,0.69699999999999995,0.88800000000000001,null,0.71299999999999997,0.71199999999999997,0.70799999999999996,0.93]
["Undiscounted Current Accident Year Loss Ratio (excl. Nat Cats)",null,0.68400000000000005,0.70699999999999996,0.66500000000000004,0.753,null,0.68700000000000006,0.70299999999999996,0.68,0.74099999999999999]
["Undiscounted Current Accident Year Nat Cats",null,4.1000000000000002E-2,2.7E-2,4.4999999999999998E-2,0.14499999999999999,null,0.05,3.4000000000000002E-2,4.4999999999999998E-2,0.22]
["Current Accident Year Discounting",null,-1.7000000000000001E-2,-1.9E-2,-1.2999999999999999E-2,-0.01,null,-2.4E-2,-2.5000000000000001E-2,-1.7000000000000001E-2,-3.1E-2]
["Prior Year Reserve Development Ratio",null,0.01,1.0999999999999999E-2,1.2999999999999999E-2,-3.4000000000000002E-2,null,1.7000000000000001E-2,1.7999999999999999E-2,1.7000000000000001E-2,-2.8000000000000001E-2]
["Expense Ratio",null,0.24399999999999999,0.23100000000000001,0.26200000000000001,9.4E-2,null,0.247,0.23499999999999999,0.26100000000000001,0.109]
["Combined Ratio",null,0.96199999999999997,0.95799999999999996,0.97199999999999998,0.94799999999999995,null,0.97599999999999998,0.96499999999999997,0.98699999999999999,1.012]
["Technical Margin",null,944,682,234,75,null,1213,1164,220,-35]
["Long-term Business"]
["CSM Release"]
["Technical Experience"]
["Financial Result & Other"]
["Financial Result",null,1288,925,309,75,null,2504,1833,554,162]
["Investment Income",null,1532,1091,307,156,null,2968,2147,544,322]
["Insurance Finance Expenses",null,-244,-166,3,-81,null,-463,-314,10,-159]
["Other Revenues"]
["Other Expenses"]
["Debt Financing Charges"]
["Underlying Earnings Before Tax",null,2231,1607,543,151,null,3718,2997,774,127]
["Tax",null,-455,null,null,null,null,-781]
["Income from Affiliates & Other",null,20,null,null,null,null,74]
["Minority Interests",null,-47,null,null,null,null,-80]
["Underlying Earnings Group share",null,1750,null,null,null,null,2931]
[]
["Closing Invested Assets",null,112087,null,null,null,null,105761]
[]
["For short-term business"]
["Liabilities for remaining coverage",null,21863,15064,6352,2018,null,17120,11085,4929,1240]
["Best Estimate Liabilities for Incurred Claims",null,85845,66083,17905,8745,null,84340,65509,17189,8488]
[]
["For long-term business"]
["Best Estimate Liabilities"]

{"sheet":"6. P&C UE by Geography","index":7,"n_rows":39,"n_cols":17,"rows_kept":39,"cut":false,"hidden":false,"merged":[[1,0,1,16],[2,15,2,16],[3,15,3,16],[5,0,6,0],[5,2,5,8],[5,10,5,16]]}
["Back to Summary"]
["PROPERTY & CASUALTY PROFITABILITY ANALYSIS BY GEOGRAPHY"]
[null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"AXA Consolidated"]
["(in Euro million)",null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Financial Statements"]
[null,null,"Total","France","Europe","AXA XL","o/w AXA XL\n Insurance","Asia, Africa & \nEME-LATAM","Transversal & \nOther",null,"Total","France","Europe","AXA XL","o/w AXA XL \nInsurance","Asia, Africa &\n EME-LATAM","Transversal & \nOther"]
["Property & Casualty Underlying Earnings by Geography",null,"2022-06-30",null,null,null,null,null,null,null,"2022-12-31"]
[null,null,"Total","France","Europe","AXA XL","o/w AXA XL\n Insurance","Asia, Africa & \nEME-LATAM","Transversal & \nOther",null,"Total","France","Europe","AXA XL","o/w AXA XL \nInsurance","Asia, Africa &\n EME-LATAM","Transversal & \nOther"]
["Short-term Business"]
["Revenues",null,24614,3784,8718,8930,7482,2371,811,null,50798,7820,17738,18777,15809,4786,1677]
["Current Accident Year Loss Ratio",null,0.70799999999999996,0.73699999999999999,0.68200000000000005,0.746,0.71799999999999997,0.66200000000000003,0.56499999999999995,null,0.71299999999999997,0.73099999999999998,0.68700000000000006,0.752,0.71799999999999997,0.68700000000000006,0.53800000000000003]
["Undiscounted Current Accident Year Loss Ratio (excl. Nat Cats)",null,0.68400000000000005,0.72099999999999997,0.65300000000000002,0.71399999999999997,0.70699999999999996,0.66400000000000003,0.56699999999999995,null,0.68700000000000006,0.71099999999999997,0.66700000000000004,0.70799999999999996,0.70099999999999996,0.68899999999999995,0.53600000000000003]
["Undiscounted Current Accident Year Nat Cats",null,4.1000000000000002E-2,4.9000000000000002E-2,4.1000000000000002E-2,5.0999999999999997E-2,3.3000000000000002E-2,7.0000000000000001E-3,2E-3,null,0.05,5.6000000000000001E-2,3.9E-2,7.1999999999999995E-2,4.3999999999999997E-2,6.0000000000000001E-3,0.01]
["Current Accident Year Discounting",null,-1.7000000000000001E-2,-3.3000000000000002E-2,-1.2E-2,-1.9E-2,-2.1000000000000001E-2,-8.9999999999999993E-3,-5.0000000000000001E-3,null,-2.4E-2,-3.5999999999999997E-2,-1.9E-2,-2.8000000000000001E-2,-2.7E-2,-8.9999999999999993E-3,-7.0000000000000001E-3]
["Prior Year Reserve Development Ratio",null,0.01,3.5000000000000003E-2,2.4E-2,-1.9E-2,-1.6E-2,1.0999999999999999E-2,4.1000000000000002E-2,null,1.7000000000000001E-2,9.7000000000000003E-2,1.4999999999999999E-2,-1.2E-2,-0.01,8.9999999999999993E-3,1.4999999999999999E-2]
["Expense Ratio",null,0.24399999999999999,0.21299999999999999,0.26400000000000001,0.20100000000000001,0.221,0.313,0.46800000000000003,null,0.247,0.214,0.26900000000000002,0.20100000000000001,0.218,0.311,0.499]
["Combined Ratio",null,0.96199999999999997,0.98499999999999999,0.96899999999999997,0.92700000000000005,0.92300000000000004,0.98599999999999999,1.0740000000000001,null,0.97599999999999998,1.042,0.97,0.94,0.92700000000000005,1.006,1.052]
["Technical Margin",null,944,55,267,648,573,33,-60,null,1213,-327,537,1119,1154,-28,-88]
["Long-term Business"]
["CSM Release"]
["Technical Experience"]
["Financial Result & Other"]
["Financial Result",null,1288,251,554,254,178,202,28,null,2504,498,1049,543,381,360,53]
["Investment Income",null,1532,239,560,487,331,219,28,null,2968,475,1074,979,658,386,53]
["Insurance Finance Expenses",null,-244,11,-6,-233,-152,-17,0,null,-463,23,-25,-436,-277,-25,0]
["Other Revenues"]
["Other Expenses"]
["Debt Financing Charges"]
["Underlying Earnings Before Tax",null,2231,306,820,902,751,235,-32,null,3718,171,1586,1662,1535,333,-34]
["Tax",null,-455,-71,-170,-172,-146,-53,12,null,-781,-54,-343,-310,-279,-82,8]
["Income from Affiliates & Other",null,20,"-",0,"-","-",20,"-",null,74,"-",0,"-","-",74,"-"]
["Minority Interests",null,-47,0,-24,-1,-1,-22,0,null,-80,0,-52,0,0,-28,0]
["Underlying Earnings Group share",null,1750,234,627,729,604,180,-21,null,2931,117,1191,1352,1257,296,-26]
[]
["For short-term business"]
["Liabilities for remaining coverage",null,21863,2171,7137,10140,8199,1940,475,null,17120,1846,4709,8476,7240,1636,453]
["Best Estimate Liabilities for Incurred Claims",null,85845,13919,25014,41313,32739,3862,1737,null,84340,14324,24411,40203,32025,3684,1719]
[]
["For long-term business"]
["Best Estimate Liabilities"]

{"sheet":"7. L&H UE by LOB","index":8,"n_rows":39,"n_cols":9,"rows_kept":39,"cut":false,"hidden":false,"merged":[[1,0,1,8],[3,7,3,8],[5,0,6,0],[5,2,5,4],[5,6,5,8]]}
["Back to Summary"]
["LIFE & HEALTH PROFITABILITY ANALYSIS BY LINE OF BUSINESS"]
[]
["(in Euro million)",null,null,null,null,null,null,"Financial Statements"]
[]
["Life & Health Underlying Earnings by Line of Business",null,"2022-06-30",null,null,null," December 31, 2022"]
[null,null,"Total","Life","Health",null,"Total","Life","Health"]
["Short-term Business"]
["Revenues",null,7647,1979,5668,null,15849,4001,11848]
["Combined Ratio",null,0.96899999999999997,0.93300000000000005,0.98099999999999998,null,0.97499999999999998,0.94199999999999995,0.98599999999999999]
["Technical Margin",null,241,132,109,null,396,233,163]
["Long-term Business"]
["CSM Release",null,1454,1177,277,null,3013,2451,563]
["Technical Experience",null,-66,-50,-16,null,-216,-112,-104]
["Actual vs. Expected Best Estimate Cash Flows",null,-43,-27,-15,null,-186,-87,-100]
["Risk Adjustment Release",null,52,46,6,null,92,82,10]
["Changes in Onerous Contracts",null,-32,-31,-1,null,4,-5,9]
["Other Long-term",null,-44,-38,-6,null,-126,-102,-24]
["Financial Result & Other"]
["Financial Result",null,626,511,115,null,1103,894,209]
["Investment Income",null,1381,1218,163,null,2639,2326,313]
["Insurance Finance Expenses",null,-755,-707,-48,null,-1535,-1432,-103]
["Other Revenues"]
["Other Expenses"]
["Debt Financing Charges"]
["Underlying Earnings Before Tax",null,2255,1771,484,null,4296,3466,830]
["Tax",null,-437,-326,-112,null,-849,-660,-189]
["Income from Affiliates & Other",null,109,103,7,null,185,180,5]
["Minority Interests",null,-30,-27,-3,null,-69,-65,-4]
["Underlying Earnings Group share",null,1897,1521,376,null,3563,2920,643]
[]
["Closing Invested Assets",null,356231,null,null,null,338496]
[]
["For short-term business"]
["Liabilities for remaining coverage",null,1954,186,1769,null,1672,147,1526]
["Best Estimate Liabilities for Incurred Claims",null,18391,14370,4021,null,18198,13853,4344]
[]
["For long-term business"]
["Best Estimate Liabilities",null,332125,312113,20013,null,312023,293072,18950]

{"sheet":"8. L&H UE by Geography","index":9,"n_rows":37,"n_cols":15,"rows_kept":37,"cut":false,"hidden":false,"merged":[[1,0,1,14],[2,13,2,14],[3,13,3,14],[5,0,6,0],[5,2,5,7],[5,9,5,14]]}
["Back to Summary"]
["LIFE & HEALTH PROFITABILITY ANALYSIS BY GEOGRAPHY"]
[null,null,null,null,null,null,null,null,null,null,null,null,null,"AXA Consolidated"]
["(in Euro million)",null,null,null,null,null,null,null,null,null,null,null,null,"Financial Statements"]
[null,null,"Total","France","Europe","AXA XL","Asia, Africa & \nEME-LATAM","Transversal & \nOther",null,"Total","France","Europe","AXA XL","Asia, Africa & \nEME-LATAM","Transversal & \nOther"]
["Life & Health Underlying Earnings by Geography",null,"2022-06-30",null,null,null,null,null,null,"2022-12-31"]
[null,null,"Total","France","Europe","AXA XL","Asia, Africa & \nEME-LATAM","Transversal & \nOther",null,"Total","France","Europe","AXA XL","Asia, Africa & \nEME-LATAM","Transversal & \nOther"]
["Short-term Business"]
["Revenues",null,7647,5195,1335,"-",988,129,null,15849,10642,2774,"-",2164,269]
["Combined Ratio",null,0.96899999999999997,0.96599999999999997,0.95299999999999996,"-",1.004,0.97799999999999998,null,0.97499999999999998,0.98,0.92700000000000005,"-",1.0089999999999999,0.98599999999999999]
["Technical Margin",null,241,179,63,"-",-4,3,null,396,208,202,"-",-18,4]
["Long-term Business"]
["CSM Release",null,1454,423,475,3,554,0,null,3013,944,940,3,1126,0]
["Technical Experience",null,-66,-50,21,-2,-34,0,null,-216,-74,-7,-3,-132,0]
["Actual vs. Expected Best Estimate Cash Flows",null,-43,-13,-11,-3,-16,0,null,-186,1,-48,-4,-137,0]
["Risk Adjustment Release",null,52,16,25,0,11,"-",null,92,28,45,1,20,"-"]
["Changes in Onerous Contracts",null,-32,"-",-22,"-",-10,0,null,4,"-",-24,"-",28,0]
["Other Long-term",null,-44,-53,29,0,-20,0,null,-126,-103,20,0,-43,0]
["Financial Result & Other"]
["Financial Result",null,626,208,285,11,122,0,null,1103,380,527,20,176,0]
["Investment Income",null,1381,398,511,13,460,0,null,2639,746,994,24,874,0]
["Insurance Finance Expenses",null,-755,-190,-225,-2,-338,0,null,-1535,-366,-467,-4,-698,0]
["Other Revenues"]
["Other Expenses"]
["Debt Financing Charges"]
["Underlying Earnings Before Tax",null,2255,759,844,11,637,3,null,4296,1459,1662,20,1151,4]
["Tax",null,-437,-135,-174,-2,-125,-1,null,-849,-289,-333,-3,-224,1]
["Income from Affiliates & Other",null,109,3,0,"-",106,0,null,185,13,0,"-",172,"-"]
["Minority Interests",null,-30,-2,-23,"-",-5,0,null,-69,-3,-62,"-",-4,0]
["Underlying Earnings Group share",null,1897,626,647,9,613,2,null,3563,1180,1266,17,1095,4]
[]
["For short-term business"]
["Liabilities for remaining coverage",null,1954,20,1100,"-",825,9,null,1672,25,804,"-",836,8]
["Best Estimate Liabilities for Incurred Claims",null,18391,17333,510,"-",522,26,null,18198,17253,440,"-",477,28]
[]
["For long-term business"]
["Best Estimate Liabilities",null,332125,134949,142228,2185,52763,"-",null,312023,128197,133319,1905,48602,"-"]

{"sheet":"9. Life UE by Geography","index":10,"n_rows":37,"n_cols":15,"rows_kept":37,"cut":false,"hidden":false,"merged":[[1,0,1,14],[2,13,2,14],[3,13,3,14],[5,0,6,0],[5,2,5,7],[5,9,5,14]]}
["Back to Summary"]
["LIFE PROFITABILITY ANALYSIS BY GEOGRAPHY"]
[null,null,null,null,null,null,null,null,null,null,null,null,null,"AXA Consolidated"]
["(in Euro million)",null,null,null,null,null,null,null,null,null,null,null,null,"Financial Statements"]
[]
["Life Underlying Earnings by Geography",null,"2022-06-30",null,null,null,null,null,null,"2022-12-31"]
[null,null,"Total","France","Europe","AXA XL","Asia, Africa & \nEME-LATAM","Transversal &\n Other",null,"Total","France","Europe","AXA XL","Asia, Africa &\n EME-LATAM","Transversal &\n Other"]
["Short-term Business"]
["Revenues",null,1979,1839,47,"-",92,"-",null,4001,3639,93,"-",269,"-"]
["Combined Ratio",null,0.93300000000000005,0.92700000000000005,0.92,"-",1.0609999999999999,"-",null,0.94199999999999995,0.94499999999999995,0.77600000000000002,"-",0.95599999999999996,"-"]
["Technical Margin",null,132,134,4,"-",-6,"-",null,233,200,21,"-",12,"-"]
["Long-term Business"]
["CSM Release",null,1177,423,415,3,336,"-",null,2451,944,796,3,707,"-"]
["Technical Experience",null,-50,-50,20,-2,-18,"-",null,-112,-74,-4,-3,-31,"-"]
["Actual vs. Expected Best Estimate Cash Flows",null,-27,-13,-12,-3,1,"-",null,-87,1,-47,-4,-37,"-"]
["Risk Adjustment Release",null,46,16,23,0,7,"-",null,82,28,42,1,12,"-"]
["Changes in Onerous Contracts",null,-31,"-",-21,"-",-10,"-",null,-5,0,-35,"-",29,"-"]
["Other Long-term",null,-38,-53,31,0,-16,"-",null,-102,-103,37,0,-36,"-"]
["Financial Result & Other"]
["Financial Result",null,511,169,250,11,81,"-",null,894,311,467,20,96,"-"]
["Investment Income",null,1218,362,481,13,363,"-",null,2326,677,937,24,689,"-"]
["Insurance Finance Expenses",null,-707,-193,-231,-2,-282,"-",null,-1432,-366,-469,-4,-593,"-"]
["Other Revenues"]
["Other Expenses"]
["Debt Financing Charges"]
["Underlying Earnings Before Tax",null,1771,676,690,11,394,"-",null,3466,1381,1280,20,784,"-"]
["Tax",null,-326,-120,-135,-2,-68,"-",null,-660,-274,-243,-3,-140,"-"]
["Income from Affiliates & Other",null,103,3,0,"-",99,"-",null,180,13,0,0,167,"-"]
["Minority Interests",null,-27,-2,-23,"-",-2,"-",null,-65,-3,-60,0,-2,"-"]
["Underlying Earnings Group share",null,1521,557,531,9,423,"-",null,2920,1118,977,17,809,"-"]
[]
["For short-term business"]
["Liabilities for remaining coverage",null,186,22,32,"-",132,"-",null,147,20,1,0,126,"-"]
["Best Estimate Liabilities for Incurred Claims",null,14370,14062,152,"-",156,"-",null,13853,13615,61,"-",178,"-"]
[]
["For long-term business"]
["Best Estimate Liabilities",null,312113,134949,122032,2185,52946,"-",null,293072,128197,114286,1905,48685,"-"]

{"sheet":"10. Health UE by Geography","index":11,"n_rows":37,"n_cols":15,"rows_kept":37,"cut":false,"hidden":false,"merged":[[1,0,1,14],[2,13,2,14],[3,13,3,14],[5,0,6,0],[5,2,5,7],[5,9,5,14]]}
["Back to Summary"]
["HEALTH PROFITABILITY ANALYSIS BY GEOGRAPHY"]
[null,null,null,null,null,null,null,null,null,null,null,null,null,"AXA Consolidated"]
["(in Euro million)",null,null,null,null,null,null,null,null,null,null,null,null,"Financial Statements"]
[]
["Health Underlying Earnings by Geography",null,"2022-06-30",null,null,null,null,null,null,"2022-12-31"]
[null,null,"Total","France","Europe","AXA XL","Asia, Africa & \nEME-LATAM","Transversal & \nOther",null,"Total","France","Europe","AXA XL","Asia, Africa & \nEME-LATAM","Transversal & \nOther"]
["Short-term Business"]
["Revenues",null,5668,3356,1288,"-",896,129,null,11848,7003,2681,"-",1895,269]
["Combined Ratio",null,0.98099999999999998,0.98699999999999999,0.95399999999999996,"-",0.998,0.97799999999999998,null,0.98599999999999999,0.999,0.93200000000000005,"-",1.016,0.98599999999999999]
["Technical Margin",null,109,45,60,"-",1,3,null,163,8,181,"-",-30,4]
["Long-term Business"]
["CSM Release",null,277,"-",59,"-",217,0,null,563,"-",144,"-",418,0]
["Technical Experience",null,-16,"-",0,"-",-16,0,null,-104,"-",-3,"-",-101,0]
["Actual vs. Expected Best Estimate Cash Flows",null,-15,"-",1,"-",-17,0,null,-100,"-",-1,"-",-99,0]
["Risk Adjustment Release",null,6,"-",2,"-",4,"-",null,10,"-",3,"-",7,"-"]
["Changes in Onerous Contracts",null,-1,"-",-1,"-",0,0,null,9,"-",11,"-",-1,0]
["Other Long-term",null,-6,"-",-2,"-",-4,0,null,-24,"-",-17,"-",-8,0]
["Financial Result & Other"]
["Financial Result",null,115,39,36,"-",40,0,null,209,70,59,"-",81,0]
["Investment Income",null,163,36,30,"-",97,0,null,313,70,57,"-",186,0]
["Insurance Finance Expenses",null,-48,3,6,"-",-57,0,null,-103,0,2,"-",-105,0]
["Other Revenues"]
["Other Expenses"]
["Debt Financing Charges"]
["Underlying Earnings Before Tax",null,484,84,155,"-",243,3,null,830,77,382,"-",368,4]
["Tax",null,-112,-15,-39,"-",-57,-1,null,-189,-15,-90,"-",-84,1]
["Income from Affiliates & Other",null,7,"-",0,"-",7,0,null,5,"-",0,"-",5,"-"]
["Minority Interests",null,-3,"-",0,"-",-3,0,null,-4,"-",-2,"-",-2,0]
["Underlying Earnings Group share",null,376,69,116,"-",190,2,null,643,62,290,"-",286,4]
[]
["For short-term business"]
["Liabilities for remaining coverage",null,1769,-2,1069,"-",693,9,null,1526,5,803,"-",710,8]
["Best Estimate Liabilities for Incurred Claims",null,4021,3271,358,"-",367,26,null,4344,3638,379,"-",299,28]
[]
["For long-term business"]
["Best Estimate Liabilities",null,20013,"-",20196,"-",-183,"-",null,18950,"-",19033,"-",-82,"-"]

{"sheet":"11. Asset Management","index":12,"n_rows":37,"n_cols":7,"rows_kept":37,"cut":false,"hidden":false,"merged":[[6,2,6,3],[6,5,6,6],[10,3,12,3],[10,6,12,6],[1,0,1,6],[2,0,2,6],[3,0,4,0],[3,5,3,6],[4,5,4,6],[5,2,5,3],[5,5,5,6]]}
["Back to Summary"]
["ASSET MANAGEMENT - ASSETS UNDER MANAGEMENT (AUM) ROLLFORWARD & PROFITABILITY ANALYSIS"]
[]
["(in Euro million unless otherwise mentioned) ",null,null,null,null,"AXA Consolidated"]
[null,null,null,null,null,"Financial Statements"]
[]
[null,null,"2022-06-30",null,null,"2022-12-31"]
[null,null,"Total","o/w Third Party",null,"Total","o/w Third Party"]
["Opening AUM (in Euro billion)\n",null,910,321,null,910,321]
["Net Inflows",null,14,7,null,18,18]
["Scope & Other",null,0,-25,null,20,-24]
["Market Effect",null,-86,null,null,-103]
["Currency Impact",null,6,null,null,0]
["Closing AUM  (in Euro billion)\n",null,844,302,null,845,314]
["Alternatives",null,193,84,null,218,87]
["Core & Other",null,535,218,null,521,227]
["Asian Joint Ventures",null,116,"-",null,105,"-"]
[]
["Gross Revenues - After Intercompany Elimination",null,788,null,null,1589]
[]
["Gross Revenues - Before Intercompany Elimination",null,947,null,null,1916]
["Management Fees",null,695,387,null,1382,797]
["Performance Fees",null,9,7,null,23,17]
["Distribution Fees",null,188,null,null,384]
[]
["General Expenses",null,-682,null,null,-1404]
["Distribution Fees Retroceded",null,-188,null,null,-384]
["Net Investment Result",null,2,null,null,1]
["Underlying Earnings Before Tax",null,267,null,null,513]
["Tax",null,-71,null,null,-130]
["Income from Affiliates & Other",null,13,null,null,30]
["Minority Interests",null,-5,null,null,-14]
["Underlying Earnings Group Share",null,203,null,null,400]
[]
["Average AUM  (in Euro billion)",null,771,null,null,751]
["Asset Management Fee bps",null,17.83359022419636,null,null,18.178963103023939]
["Underlying Cost Income Ratio",null,0.64710177884174314,null,null,0.6655773196488135]

{"sheet":"12. Holdings","index":13,"n_rows":30,"n_cols":5,"rows_kept":30,"cut":false,"hidden":false,"merged":[[1,0,1,4]]}
["Back to Summary"]
["HOLDINGS PROFITABILITY ANALYSIS & AXA SA CASH BALANCE ROLLFORWARD"]
[null,null,null,null,"AXA Consolidated"]
["(in Euro million unless otherwise mentioned)",null,null,null,"Financial Statements"]
[]
["Holdings Underlying Earnings",null,"2022-06-30",null,"2022-12-31"]
["Other Revenues",null,576,null,1005]
["Other Expenses",null,-741,null,-1352]
["Debt Financing Charges",null,-363,null,-759]
["Underlying Earnings Before Tax",null,-528,null,-1107]
["Tax",null,146,null,292]
["Income from Affiliates & Other",null,"-",null,"-"]
["Minority Interests",null,"-",null,"-"]
["Underlying Earnings Group share",null,-383,null,-814]
[]
["Opening Cash Balance at AXA SA* (in Euro billion)",null,null,null,4.5]
["Net cash remittance from subsidiaries",null,null,null,5.5]
["Property & Casualty",null,null,null,2.9]
["Life & Health**",null,null,null,2.2999999999999998]
["Asset Management***",null,null,null,0.3]
["Dividends",null,null,null,-3.5]
["Share buy-backs",null,null,null,-2.2999999999999998]
["Holding costs and interests",null,null,null,-1]
["Debt issuance",null,null,null,1]
["M&A and disposals",null,null,null,0.6]
["Other",null,null,null,-0.2]
["Closing Cash Balance at AXA SA* ",null,null,null,4.5999999999999996]
["*Includes liquid invested assets."]
["**Includes Euro 0.3 billion from the Belgium inforce transaction."]
["***Includes Bank."]

{"sheet":"13. Activity indicators","index":14,"n_rows":25,"n_cols":17,"rows_kept":25,"cut":false,"hidden":false,"merged":[[15,0,16,0],[15,2,15,8],[15,10,15,16],[1,0,1,16],[2,15,2,16],[3,15,3,16],[5,0,6,0],[5,2,5,8],[5,10,5,16]]}
["Back to Summary"]
["GROSS WRITTEN PREMIUMS, NEW BUSINESS VALUE & PRESENT VALUE OF EXPECTED PREMIUMS"]
[null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"AXA Consolidated"]
["(in Euro million)",null,null,null,null,null,null,null,null,null,null,null,null,null,null,"Financial Statements"]
[]
["Activity Indicators by Line of Business",null," Period ended June 30, 2022",null,null,null,null,null,null,null," Period ended December 31, 2022"]
[null,null,"Total","P&C","Life & Health","Life","Health","Asset Management","Bank",null,"Total","P&C","Life & Health","Life","Health","Asset Management","Bank"]
["Gross Written Premiums",null,54867,28713,25287,16553,8734,788,80,null,101844,50633,49485,32231,17254,1589,137]
["IFRS17/9 New Business Value (NBV) (a)",null,1323,null,1323,1094,229,null,null,null,2288,null,2288,1830,459]
["New Business Contractual Service Margin (NB CSM)",null,1209,null,1209,1011,199,null,null,null,2355,null,2355,1935,420]
["Other NBV*",null,527,null,527,421,106,null,null,null,665,null,665,481,184]
["Tax",null,-413,null,-413,-338,-75,null,null,null,-731,null,-731,-586,-145]
["Present Value of Expected Premiums (PVEP) (b)",null,25912,null,25912,19410,6502,null,null,null,43320,null,43320,31634,11686]
["IFRS17 NBV Margin (a)/(b)",null,5.0999999999999997E-2,null,5.0999999999999997E-2,5.6000000000000001E-2,3.5000000000000003E-2,null,null,null,5.2999999999999999E-2,null,5.2999999999999999E-2,5.8000000000000003E-2,3.9E-2]
[null,null,null,null,null,null,"Asia EME LATAM and Africa",null,null,null,null,null,null,null,"Asia EME LATAM and Africa"]
["Activity Indicators by Geography",null," Period ended June 30, 2022",null,null,null,null,null,null,null," Period ended December 31, 2022"]
[null,null,"Total","France","Europe","AXA XL","Asia, Africa &\n EME-LATAM","AXA IM","Transversal & Other",null,"Total","France","Europe","AXA XL","Asia, Africa & \nEME-LATAM","AXA IM","Transversal & Other"]
["Gross Written Premiums",null,54867,14507,20251,10252,8152,788,917,null,101844,28627,35045,18577,16225,1589,1782]
["IFRS17/9 New Business Value (NBV) (a)",null,1323,330,402,null,591,null,null,null,2288,605,559,null,1124]
["New Business Contractual Service Margin (NB CSM)",null,1209,232,376,null,602,null,null,null,2355,475,646,null,1234]
["Other NBV*",null,527,199,135,null,193,null,null,null,665,318,84,null,263]
["Tax",null,-413,-101,-108,null,-204,null,null,null,-731,-188,-170,null,-373]
["Present Value of Expected Premiums (PVEP) (b)",null,25912,12806,5761,null,7345,null,null,null,43320,19809,10079,null,13432]
["IFRS17 NBV Margin (a)/(b)",null,5.0999999999999997E-2,2.5999999999999999E-2,7.0000000000000007E-2,null,0.08,null,null,null,5.2999999999999999E-2,3.1E-2,5.5E-2,null,8.4000000000000005E-2]
["*Includes expected profits from short term Life & Health business, carried by Life entities, Pure Investment Contracts, NBV from Equity method entities as well as New Business Loss Components and Margin ceded to reinsurers. "]

{"sheet":"14. Balance Sheet","index":15,"n_rows":24,"n_cols":11,"rows_kept":24,"cut":false,"hidden":false,"merged":[[1,0,1,10],[2,9,2,10],[3,9,3,10]]}
["Back to Summary"]
["BALANCE SHEET"]
[null,null,null,null,null,null,null,null,null,"AXA Consolidated"]
["(in Euro billion) ",null,null,null,null,null,null,null,null,"Financial Statements"]
[]
["Assets",null," December 31, 2021"," June 30, 2022"," December 31, 2022",null,"Liabilities, Minority Interests & Shareholders' Equity",null," December 31, 2021"," June 30, 2022"," December 31, 2022"]
[]
["Goodwill",null,17.2,18,17.8,null,"Shareholders' Equity group share",null,51.9,48.6,46.3]
["Other intangible assets",null,4.8,4.8,4.7,null,"Minority Interests",null,3.7,3.5,3]
["Total Intangible assets",null,21.9,22.8,22.5,null,"Shareholders’ equity ",null,55.6,52.1,49.3]
["Investments in real estate properties",null,28,28.3,28.7,null,"Financing debt",null,11.4,13.3,13.6]
["Financial investments",null,486.1,412.5,389.6,null,"Liabilities arising from insurance contracts and investment contracts with discretionary participation features contracts",null,539.4,460.6,444.5]
["Unit-linked Assets",null,86.2,76,76.5,null,"Present Value of Fulfillment Cash Flows ",null,501.3,423.2,407.3]
["Total Investments from insurance activities",null,600.29999999999995,516.79999999999995,494.8,null,"Contractual Service Margin ",null,34.299999999999997,34,34.200000000000003]
["Investments from Non-Insurrance Activities",null,20.6,20.100000000000001,20.8,null,"Risk Adjustment ",null,3.8,3.4,3.1]
["Equity Method investments",null,2.5,2.2000000000000002,2.2000000000000002,null,"Other Investment Contract Liabilities",null,14.5,12.7,12.4]
["Assets Arising from Insurance and Reinsurance Contracts Held",null,25.8,24.7,24.4,null,"Liabilities arising from insurance, reinsurance and investment contracts",null,553.79999999999995,473.3,456.9]
["Present Value of Fulfillment Cash Flows",null,24.6,23.3,23.2,null,"Liabilities Arising from Non-Insurance Activities",null,14.7,12,12.2]
["Contractual Service Margin",null,0.7,0.9,0.7,null,"Provisions for risks and charges",null,9.4,6.6,6.5]
["Risk Adjustment",null,0.5,0.5,0.5,null,"Payables and Other liabilities ",null,78.599999999999994,89.1,88.3]
["Receivables and Other Assets ",null,26.4,34.4,34.9,null,"Liabilities held for sale ",null,7.2,19.600000000000001,13]
["Assets held for sale",null,8.1,20.3,14.1,null,"Total Liabilities, Minority Interests and Shareholders' Equity",null,730.7,666,639.9]
["Cash and cash equivalents",null,25.1,24.8,26.2]
["Total Assets",null,730.7,666,639.9]

{"sheet":"15.CSM Rollforward","index":16,"n_rows":21,"n_cols":8,"rows_kept":21,"cut":false,"hidden":false,"merged":[[1,0,1,7]]}
["Back to Summary"]
["CONTRACTUAL SERVICE MARGIN ROLLFORWARD"]
[null,null,null,null,null,null,null,"AXA Consolidated"]
["(in Euro billion)",null,null,null,null,null,null,"Financial Statements"]
[]
["Contractual Service Margin (CSM)","2021-12-31","New Business CSM","Economic Variance","Operating Variance ","Change in scope and FX impact","CSM Release","2022-06-30"]
[]
[]
["Total Group (pre-tax)",33.6,1.2,-1,0.8,-0.1,-1.5,33.1]
["Property & Casualty",0.2,"-","-","-",0,"-",0.2]
["Life",24.6,1,-0.2,1,0.2,-1.2,25.4]
["Health",8.8000000000000007,0.2,-0.8,-0.2,-0.3,-0.3,7.5]
["Total Group (post-tax)",26.2,null,null,null,null,null,26.1]
[]
["Contractual Service Margin (CSM)","2021-12-31","New Business CSM","Economic Variance","Operating Variance ","Change in scope and FX impact","CSM Release","2022-12-31"]
[]
["Total Group (pre-tax)",33.6,2.4,-0.8,1.4,-0.1,-3,33.5]
["Property & Casualty",0.2,"-","-","-",0,"-",0.2]
["Life",24.6,1.9,0,1.3,0.2,-2.5,25.5]
["Health",8.8000000000000007,0.4,-0.8,0.1,-0.3,-0.6,7.8]
["Total Group (post-tax)",26.2,null,null,null,null,null,26.3]

{"sheet":"16. FY22 Invested Assets","index":17,"n_rows":25,"n_cols":13,"rows_kept":25,"cut":false,"hidden":false,"merged":[[1,0,1,12],[5,0,6,0],[5,1,6,1],[5,2,6,2],[5,3,6,3],[5,4,6,4],[5,6,5,12],[24,0,24,5],[26,0,26,5],[19,0,20,4],[19,6,20,12],[21,0,21,5],[22,0,22,5],[23,0,23,5]]}
["Back to Summary"]
["ECONOMIC VIEW OF INVESTED ASSETS"]
[null,null,null,null,null,null,null,null,null,null,null,null,"AXA Consolidated"]
["(in Euro billion)",null,null,null,null,null,null,null,null,null,null,null,"Financial Statements"]
[]
["General Account Invested Assets\nPeriod ended December 31, 2022","Fair value","Asset \nAllocation \n%","o/w Participating","Duration gap",null,"Fair Value by Rating"]
[null,null,null,null,null,null,"Average \nrating","AAA","AA","A","BBB","Below Investment Grade","Non Rated1"]
["General Account Invested Assets1",461,null,0.59,"0.5 yr"]
["Fixed Income",340,0.74,0.61]
["Government Bonds",167,0.36,0.66,null,null,"AA",0.19,0.47,0.2,0.12,0.01,0.02]
["Corporate Bonds",124,0.27,0.55000000000000004,null,null,"A",0.12,0.09,0.33,0.35,0.1]
["Other Fixed Income",48,0.1,0.59]
["        Asset Backed Securities2",18,0.04,null,null,null,null,0.59,0.27,0.1,0,0.02,0.03]
["        Mortgage Loans3",30,0.06]
["Real Estate4",50,0.11,0.62]
["Listed Equities",15,0.03,0.79]
["Private Equity & Hedge Funds5",29,0.06,0.43]
["Cash",26,0.06,0.44]
["Policy Loans",2,0,0.36]
["1 Reflects the fair value of assets excluding the minority interest share in assets held in fully consolidated invested funds, hedging derivatives, Unit-linked assets and investments from non-insurance activities.",null,null,null,null,null,"1 Corporate bonds not rated by external rating agencies are reallocated under AXA’s internal ratings: AAA: Euro 1.2 billion, AA: Euro 0.5 billion, A: Euro 3.2 billion, BBB: Euro 1.4 billion, Below investment grade: Euro 4.1 billion."]
[]
["2 Includes 96% of CLOs."]
["3 Residential loans (Euro 16 billion), commercial & agricultural loans (Euro 9 billion) and Agency Pools (Euro 4 billion)."]
["4 Includes Infrastructure Equities (Euro 7 billion)."]
["5 Private Equity (Euro 18 billion), Hedge Funds (Euro 5 billion) and Non-listed Equities (Euro 6 billion)."]

{"sheet":"17. Supplementary Info on Asset","index":18,"n_rows":56,"n_cols":14,"rows_kept":56,"cut":false,"hidden":false,"merged":[[32,0,33,0],[1,0,1,13],[8,0,9,0],[13,0,14,0],[23,0,23,1],[28,0,29,0],[37,0,38,0],[41,0,42,0],[47,0,48,0],[52,0,53,0],[54,0,54,8]]}
["Back to Summary"]
["SUPPLEMENTARY INFORMATION ON ECONOMIC VIEW OF INVESTED ASSETS AS AT DECEMBER 31, 2022"]
[null,null,null,null,null,null,null,null,null,null,null,null,null,"AXA Consolidated"]
["(in Euro billion)",null,null,null,null,null,null,null,null,null,null,null,null,"Financial Statements"]
[]
[]
["Government Bonds"]
[]
["Breakdown By Geographical Exposure","Fair Value","Belgium","France","Germany","Italy","Japan","Netherlands","Spain","Switzerland","United States","Other EU countries","Supranational","Rest of the World"]
[null,167,7.0000000000000007E-2,0.19,7.0000000000000007E-2,0.09,0.14000000000000001,0.03,0.05,0.08,0.06,0.02,7.0000000000000007E-2,0.13]
[]
["Corporate Bonds"]
[]
["Breakdown By Industry","Fair Value","Basic Materials","Communications","Consumer, Cyclical","Consumer, Non-Cyclical","Energy","Financials","Industrial","Technology","Utilities","Other"]
[null,124,0.03,7.0000000000000007E-2,0.06,0.13,0.05,0.42,0.08,0.03,0.08,0.05]
[]
[]
["Exposure to the Financials","Total","Banks","Non-Banks1"]
["Total",53,45,8]
["Covered and Senior Secured Bonds",18,17,1]
["Senior Unsecured Bonds",29,22,7]
["Subordinated Bonds2",4,4,"-"]
["Other",2,2,"-"]
["1  Includes REITS corporate bonds (Euro 5  billion)."]
["2  Includes AT1 (Euro 0.3 billion)."]
[]
["Listed Equities"]
[]
["Breakdown By Asset Domiciliation","Fair Value","Belgium","France","Germany","Japan","Netherlands","Switzerland","United States","Other EU countries","Rest of the World"]
[null,15,0.04,0.16,0.05,0.05,0.05,0.06,0.3,0.1,0.2]
[]
[]
["Breakdown By Industry","Fair Value","Basic Materials","Communications","Consumer, Cyclical","Consumer, Non-Cyclical","Diversified","Energy","Financials","Funds","Industrial","Technology","Utilities","Other"]
[null,15,0.05,7.0000000000000007E-2,0.13,0.2,0.03,0.01,0.17,0.05,0.11,0.11,0.02,0.05]
[]
["Real Estate1"]
[]
["Breakdown By Geographical Exposure","Fair Value","Belgium","France","Germany","Italy","Japan","Spain","Switzerland","United Kingdom","United States","Other EU countries","Rest of the World"]
[null,50,0.05,0.32,0.1,0.03,0.06,0.03,0.11,0.05,0.1,0.12,0.03]
[]
[]
["Breakdown By Type","Fair Value","Office","Residential","Infrastructure Equity","Industrial-Logistic","Retail","Others"]
[null,50,0.28000000000000003,0.16,0.14000000000000001,0.14000000000000001,0.1,0.17]
["1 Includes Infrastructure Equities (Euro 7 billion)."]
[]
["Private Equities"]
[]
["Breakdown By Asset Domiciliation","Fair Value","Europe","Japan","United States","Other"]
[null,18,0.36,0.04,0.51,0.1]
[]
["Mortgage Loans1,2"]
[]
["Breakdown by Type","Fair Value","Residential","Commercial"]
[null,26,0.63,0.37]
["1 Excludes banking operations and Euro 4 billion of Agency pools (Mortgage-backed securities issues by US Government Sponsored Enterprises)."]
["2 Loan to Value: 49%."]

{"sheet":"18. Shareholders Equity","index":19,"n_rows":52,"n_cols":5,"rows_kept":52,"cut":false,"hidden":false,"merged":[[1,0,1,4]]}
["Back to Summary"]
["SHAREHOLDERS' EQUITY "]
[null,null,null,null,"AXA Consolidated "]
["(in Euro billion) ",null,null,null,"Financial Statements "]
[]
["Change in Group Share Consolidated Shareholders' Equity",null,null,"2022-06-30","2022-12-31"]
["Shareholders' Equity at Beginning of the Period",null,null,51.9,51.9]
["Paid-in Capital",null,null,-2.2000000000000002,-1.9]
["Treasury Shares",null,null,0.7,-0.5]
["Other Comprehensive Income",null,null,-4.5999999999999996,-5.4]
["Other Comprehensive Income Related to Invested Assets",null,null,-44.8,-59.2]
["Other Comprehensive Income Related to (re) Insurance Contracts",null,null,40.200000000000003,53.8]
["Other Comprehensive Income Arising from Defined Benefit Plans",null,null,1.3,0.5]
["Impact of Currency Fluctuations",null,null,1.6,1.2]
["Undated Subordinated Debt (including interest charges)",null,null,-0.8,-1.2]
["Realized Gains on Equity through Retained Earnings",null,null,0.4,0.6]
["Dividends",null,null,-3.5,-3.5]
["Net Income for the Period",null,null,3.8,5.0999999999999996]
["Other",null,null,0.1,-0.4]
["Shareholders' Equity at End of the Period",null,null,48.6,46.3]
[]
[]
[]
["Group Share Consolidated Shareholders' Equity",null,"2021-12-31","2022-06-30","2022-12-31"]
["Paid-in Capital",null,26.3,24.2,24.5]
["Treasury Shares",null,-1.7,-1,-2.2000000000000002]
["Other Comprehensive Income",null,-3.1,-7.7,-8.5]
["Other Comprehensive Income Related to Invested Assets",null,36.299999999999997,-8.5,-22.8]
["Other Comprehensive Income Related to (re) Insurance Contracts",null,-39.4,0.8,14.4]
["Other Comprehensive Income Arising from Defined Benefit Plans",null,-3.1,-1.8,-2.7]
["Translation Reserves",null,-2.9,-1.3,-1.6]
["Undated Subordinated Debt",null,6.7,6,5.7]
["Retained Earnings",null,29.6,30.3,31.1]
["Total Shareholders' Equity at the End of the Period",null,51.9,48.6,46.3]
[]
[]
["Book Value per Share",null,22,21.1,20.399999999999999]
["Shareholders' Equity + CSM per Share",null,33.1,32.4,32.1]
[]
[]
[]
["Unrealized Gains and Losses on Invested Assets (Net of Tax)",null,"2021-12-31","2022-06-30","2022-12-31"]
["Government Bonds (recyclable)",null,null,2.6,-8.4]
["Corporate Bonds (recyclable)",null,null,-6.9,-9.4]
["Cash Flow hedges (recyclable)",null,null,-5,-5.2]
["Equities (non-recyclable)",null,null,0.7,0.1]
["Others (recyclable)",null,null,0.1,0]
["Total Other Comprehensive Income Related to Invested Assets",null,null,-8.5,-22.8]
["Real Estate",null,null,10.199999999999999,10.4]
["Other Invested Assets Not Included in Shareholders' Equity",null,null,-0.9,-1.9]
["Total Unrealized Gains and Losses on Invested Assets at Cost (Net of Tax)",null,null,9.3000000000000007,8.5]
["Total Unrealized Gains and Losses on Invested Assets (Net of Tax)",null,null,0.8,-14.3]

{"sheet":"19. ROE&Gearing","index":20,"n_rows":34,"n_cols":5,"rows_kept":34,"cut":false,"hidden":false,"merged":[[1,0,1,4],[13,0,13,4],[14,0,14,4]]}
["Back to Summary"]
["  RETURN ON EQUITY, CONSOLIDATED FINANCIAL STRUCTURE & DEBT GEARING"]
[null,null,null,null,"AXA Consolidated"]
["(in Euro billion)",null,null,null,"Financial Statements"]
[]
["Return on Equity (ROE) ",null,"2022-06-30","2022-12-31","Change in % points "]
["Net Income ROE",null,0.152,0.1,"-5.2 pt"]
["Net Income (a)",null,3.8,4.9000000000000004]
["Average Adjusted Shareholders' Equity (b)",null,49.3,48.7]
[]
["Underlying ROE",null,0.13700000000000001,0.121,"-1.6 pt"]
["Underlying Earnings (a)",null,3.4,5.9]
["Average Adjusted Shareholders' Equity (b)",null,49.3,48.7]
["(a) Including adjustments to reflect net financial charges related to undated and deeply subordinated debt (recorded through shareholders' equity)."]
["(b) Excluding reserves for Other Comprehensive Income as well as undated and deeply subordinated debt (recorded through shareholders' equity)."]
[]
["Consolidated Financial Structure & Debt Gearing\n (in Euro billion) ",null,"2022-06-30","2022-12-31","Financial interest treatment"]
[" "]
["Financing Debt ",null,0.8,1.7]
["Financing Debt Instrument Issued ",null,0.8,1.7]
["Financing Debt Owed to Credit Institutions ",null,"-","-"]
["Dated Subordinated Debt ",null,12.4,12]
["Total Gross Debt (A) ",null,13.3,13.6,"P&L "]
["Undated Subordinated Notes ",null,3.8,3.5,"Equity "]
["Undated Deeply Subordinated Notes ",null,2.2000000000000002,2.2000000000000002,"Equity"]
["Total Gross Debt incl. Undated and Deeply Subordinated Notes (B) ",null,19.3,19.3]
[]
["Shareholders' Equity (Including Minority Interests) (a) (C) ",null,52.1,49.3]
["Contractual Service Margin net of tax (a) (D) ",null,26.1,26.3]
[" "]
["Shareholders' Equity + Contractual Service Margin + Gross Debt (E) = (C) + (D) + (A) ",null,91.5,89.2]
[" "]
["Debt Gearing (G) = (B) / (E) ",null,0.21,0.217]
["(a) Shareholders' equity includes undated and deeply subordinated debts. "]

{"sheet":"20. Information on Solvency II","index":21,"n_rows":37,"n_cols":10,"rows_kept":37,"cut":false,"hidden":false,"merged":[[1,0,1,9],[4,8,4,9],[26,0,27,5],[13,0,13,1]]}
["Back to Summary"]
["ELIGIBLE OWN FUNDS, SOLVENCY CAPITAL REQUIREMENT & SOLVENCY II RATIO"]
[]
[null,null,null,null,null,null,null,null,null,"AXA Consolidated"]
["(in Euro billion)",null,null,null,null,null,null,null,"Financial Statements"]
[]
["Solvency II Rollforward","2021-12-31","Regulatory & model changes","Normalized Capital Generation*","Operating variance","Economic variance (incl. FX)","Dividend & share buy-backs","Debt","M&A, In-force and Other","2022-12-31"]
["Eligible Own Fund (EOF)",62,0.7,6.7,-0.7,-2.6,-6.5,0.3,-1.4,58.5]
["Property & Casualty",null,null,2.9]
["Life & Savings ",null,null,4.3]
["Other (incl. Asset Management, Bank & Holdings)",null,null,-0.6]
["Solvency Capital Requirement (SCR)",28.6,-0.2,0,"-",-0.8,"-","-",-0.5,27.2]
["Solvency II Ratio",2.17,0.04,0.23,-0.02,-0.03,-0.23,0.01,-0.01,2.15]
["*Non-life Health is included in Property & Casualty and life-like Health is included in Life & Savings"]
[]
["EOF Tiering","Total","Unrestricted Tier 1","Restricted Tier 1","Tier 2","Tier 3"]
["EOF as of Period Ended December 31, 2021",58.5,40.700000000000003,5.7,11.4,0.7]
["Insurance Sector",55.9,38.1,5.7,11.4,0.7]
["Ancillary"]
["Subject to Transitional Measures*",8.4,null,5.7,2.7]
["Other Financial Sectors",2.6,2.6]
["EOF as of Period Ended December 31, 2022",62,44.2,6.8,10.5,0.5]
["Insurance Sector",59.1,41.4,6.8,10.5,0.5]
["Ancillary"]
["Subject to Transitional Measures*",9.8000000000000007,null,6.8,3]
["Other Financial Sectors",2.8,2.8]
["*Transitional measures on basic own funds apply on subordinated debts eligible under Solvency I regulation. These subordinated debts are also eligible under Solvency II until 2026."]
[]
[]
["Solvency II \nKey Sensitivities (in pts)","2021-12-31","2022-12-31"]
["Interest Rate +50bps","+9 pts","+8 pts"]
["Interest Rate -50bps","-14 pts","-10 pts"]
["Corporate Spread +50bps","-1 pts","-4 pts"]
["Euro Sovereign Spreads +50bps","-11 pts","-9 pts"]
["Credit Migration +50bps","-7 pts","-4 pts"]
["Equity Market +25bps","+7 pts","+11 pts"]
["Equity Market -25bps","-10 pts","-13 pts"]

{"sheet":"21. IFRS17 SHE to Group EOF","index":22,"n_rows":27,"n_cols":2,"rows_kept":27,"cut":false,"hidden":false,"merged":[[1,0,1,1],[26,0,26,1]]}
["Back to Summary"]
["RECONCILIATION FROM IFRS17/9 SHAREHOLDERS' EQUITY TO SOLVENCY II ELIGIBLE OWN FUNDS"]
[]
[null,"AXA Consolidated"]
["(in Euro billion)","Financial Statements"]
[]
["Reconciliation IFRS17/9 Shareholders' Equity to Solvency II Eligible Own Funds ","2022-12-31"]
["IFRS SHAREHOLDERS' EQUITY",49.3]
["Contractual Service Margin (net of tax)",26.3]
["IFRS SHAREHOLDERS' EQUITY inc. CSM",75.599999999999994]
["Net URCG not included in Shareholders' Equity*",8]
["Elimination Undated Subordinated Debts",-5.7]
["Elimination Undated subordinated debts",-21.6]
["Elimination Intangibles",-22.1]
["Goodwill",-17.8]
["others",-4.3]
["IFRS TANGIBLE NET ASSET VALUE",55.8]
["Foreseeable dividends and distribution",-5]
["Technical provision adjustments",-6.7]
["Risk Margin vs Risk Adjustment",-6]
["BEL adjustment",-0.7]
["Other adjustments",-3.4]
["UNRESTRICTED TIER 1",40.700000000000003]
["Restricted Tier 1 + Tier 2",17.100000000000001]
["Tier 3 ",0.7]
["GROUP ELIGIBLE OWN FUNDS",58.5]
["*Difference with IFRS17/9 off balance sheet unrealized gains on assets held at cost driven by differences in tax treatment."]

{"sheet":"Holding & Banking","index":23,"n_rows":49,"n_cols":8,"rows_kept":49,"cut":false,"hidden":true,"merged":[[5,1,6,1],[5,3,5,4],[5,6,5,7]]}
["Back to Summary"]
[]
[]
[]
[null,null,null,"Bankings"]
[null,"Group Underlying Earnings by Line of Business and Total Net Income",null,"o/w Bankings",null,null,"o/w Holding"]
[null,null,null," Period ended December 31, 2022"," Period ended December 31, 2023",null," Period ended December 31, 2022"," Period ended December 31, 2023"]
[null,"Short-term Business"]
[null,"Insurance Revenues"]
[null,"Combined Ratio"]
[null,"Technical Margin"]
[null,"Other Short-term"]
[null,"Long-term Business"]
[null,"CSM Release"]
[null,"Technical Experience"]
[null,"Other Long-term"]
[null,"Financial Results & Other"]
[null,"Financial Results (incl. Insurance Finance Expense)",null,0,0]
[null,"Other Revenues",null,0,0]
[null,"Other Expenses",null,0,0]
[null,"Debt Financing Charges",null,0,0]
[null,"Underlying Earnings Before Tax",null,0,0,null,0,0]
[null,"Tax",null,0,0,null,0,0]
[null,"Income from Affiliates & Other",null,0,0,null,0,0]
[null,"Minority Interests",null,0,0,null,0,0]
[null,"Underlying Earnings After Tax, Affiliates & Other and Minority Interests",null,0,0,null,0,0]
[null,"Underlying Earnings Growth Rate (constant FX)"]
[]
[]
[]
[]
[]
[]
[null,"Underlying Earnings After Tax, Affiliates & Other and Minority Interests"]
[]
[null,"Net Realized Capital Gains & Losses"]
[null,"Fair Value of Funds & Derivatives"]
[null,"Amortization of Intangibles"]
[null,"Restructuring Costs"]
[null,"Exceptional Items"]
[null,"Net Income After Tax, Affiliates & Other and Minority Interests"]
[]
[]
[]
[]
[]
[null,"Deeply Subordinated and Undated Subordinated Debt Charges"]
[null,"Underlying Earnings to Shareholders"]
[null,"Net Income to Shareholders"]